title: [Use of beta-adrenolytics in treatment of hyperthyroidism in pregnant women].
abstract: Use of propranolol in the treatment of hyperthyreosis in pregnant women is discussed. It was noted, that propranolol given for 24-28 days in low doses, starting from the 34th-35th week of pregnancy, and in higher doses during 5 or 2 days preceding labour diminishes clinical symptoms of hyperthyreosis. It influences thyreotropic hormone levels. No side effects were seen in neonates of mothers treated with propranolol; thyreotrophic hormone levels were within normal values.
authors.affiliation: Kliniki Ginekologiczno-Połozniczej.
authors.forename: D
authors.initials: D
authors.lastname: Pisarek-Miedzińska
authors.forename: W
authors.initials: W
authors.lastname: Czech
mesh_terms: D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D006980:Hyperthyroidism / Q000188:drug therapy*; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy*; D011433:Propranolol / Q000627:therapeutic use*
chemical_list: D011433:Propranolol
vernacular_title: Zastosowanie beta-adrenolityków w leczeniu nadczynności tarczycy u kobiet ciezarnych.